Ravi K Gupta

Summary

Affiliation: University College London
Country: UK

Publications

  1. doi request reprint High rate of HIV resuppression after viral failure on first-line antiretroviral therapy in the absence of switch to second-line therapy
    Ravindra K Gupta
    Department of Infection
    Clin Infect Dis 58:1023-6. 2014
  2. pmc Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention
    Ravindra K Gupta
    Division of Infection and Immunity, University College, 90 Gower St, London WC1E 6BT, UK
    Retrovirology 10:82. 2013
  3. pmc HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef
    Daniel Sauter
    Institute of Molecular Virology, Ulm University Medical Center, 89069, Ulm, Germany
    Retrovirology 8:103. 2011
  4. doi request reprint Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine
    Ravindra K Gupta
    Division of Infection and Immunity, University College London Medical School, London, United Kingdom
    Pediatr Infect Dis J 29:e57-62. 2010
  5. pmc The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains
    Jean L Mbisa
    Virus Reference Department, Microbiology Services, Colindale, Health Protection Agency, London, UK
    Retrovirology 8:31. 2011

Collaborators

Detail Information

Publications5

  1. doi request reprint High rate of HIV resuppression after viral failure on first-line antiretroviral therapy in the absence of switch to second-line therapy
    Ravindra K Gupta
    Department of Infection
    Clin Infect Dis 58:1023-6. 2014
    ..This supports World Health Organization recommendations that suspected viral failure should trigger adherence counseling and repeat measurement before a treatment switch is considered. ..
  2. pmc Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention
    Ravindra K Gupta
    Division of Infection and Immunity, University College, 90 Gower St, London WC1E 6BT, UK
    Retrovirology 10:82. 2013
    ....
  3. pmc HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef
    Daniel Sauter
    Institute of Molecular Virology, Ulm University Medical Center, 89069, Ulm, Germany
    Retrovirology 8:103. 2011
    ..Here, we examined how long Group P may have been circulating in humans and determined its capability to antagonize human tetherin as an indicator of adaptation to humans...
  4. doi request reprint Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine
    Ravindra K Gupta
    Division of Infection and Immunity, University College London Medical School, London, United Kingdom
    Pediatr Infect Dis J 29:e57-62. 2010
    ..There are few medium-term virologic data in children from resource-limited settings taking adult fixed-dose-combination antiretroviral therapy (cART) without viral load monitoring...
  5. pmc The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains
    Jean L Mbisa
    Virus Reference Department, Microbiology Services, Colindale, Health Protection Agency, London, UK
    Retrovirology 8:31. 2011
    ..In this study we examined the genotypic, phenotypic and fitness correlates associated with the development of Q151M MDR in the absence of viral load monitoring...